Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-073960
Filing Date
2024-06-21
Accepted
2024-06-21 16:30:07
Documents
3
Group Members
NOVARTIS BIDCO AGNOVARTIS BIDCO GERMANY AGNOVARTIS PHARMA AG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2410988d28_sc13da.htm SC 13D/A 117794
2 EXHIBIT 8 tm2410988d28_ex8.htm EX-8 12199
3 EXHIBIT 9 tm2410988d28_ex9.htm EX-9 17360
  Complete submission text file 0001104659-24-073960.txt   149113
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Subject) CIK: 0001340243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90872 | Film No.: 241060835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)